The Efficacy of Lidocaine in Disrupting Cocaine Cue-Induced Memory Reconsolidation

•Lidocaine, a sodium channel blocker, inhibits NMDA receptor activation and suppresses nitric oxide and ERK production, which are crucial for memory reconsolidation.•Treatment-seeking cocaine-dependent participants were randomly assigned in a double-blind design to either receive intravenous lidocai...

Full description

Saved in:
Bibliographic Details
Published inDrug and alcohol dependence Vol. 212; p. 108062
Main Authors Becker, Josh E., Price, Julianne L., Leonard, David, Suris, Alina, Kandil, Enas, Shaw, Meredith, Kroener, Sven, Brown, E Sherwood, Adinoff, Bryon
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.07.2020
Elsevier Science Ltd
Subjects
Online AccessGet full text
ISSN0376-8716
1879-0046
1879-0046
DOI10.1016/j.drugalcdep.2020.108062

Cover

Loading…
More Information
Summary:•Lidocaine, a sodium channel blocker, inhibits NMDA receptor activation and suppresses nitric oxide and ERK production, which are crucial for memory reconsolidation.•Treatment-seeking cocaine-dependent participants were randomly assigned in a double-blind design to either receive intravenous lidocaine immediately following a cocaine craving script (lidocaine/craving), saline following a craving script (saline/craving), or lidocaine following a relaxation script (lidocaine/relax).•One week following the infusion, cue-induced craving was assessed in the same paradigm without an infusion.•Lidocaine administered following craving induction did not decrease subsequent cue-induced craving or cocaine use.•Blocking the reconsolidation of craving-related memories with pharmacological agents remains an important area of investigation. Cue-induced craving memories, linked to drug-seeking behaviors, require key molecular processes for memory reconsolidation. Lidocaine, a sodium channel blocker, inhibits NMDA receptor activation and suppresses nitric oxide and ERK production. These processes are required for memory re-consolidation; inhibiting them may reduce cue-related craving memories in cocaine dependent subjects. To assess the efficacy of lidocaine in decreasing cue-induced cocaine craving and cocaine use. Treatment-seeking cocaine-dependent participants (n = 33, 25 men) were recruited. Personalized craving and relaxation scripts were developed. Participants were then randomly assigned in a double-blind design to either receive intravenous lidocaine immediately following a cocaine craving script (lidocaine/craving), saline following a craving script (saline/craving), or lidocaine following a relaxation script (lidocaine/relax). One week following the infusion, cue-induced craving was assessed in the same paradigm without an infusion. Cocaine use and craving were assessed for 4 weeks following infusion. The administration of lidocaine during craving induction (lidocaine/craving) did not decrease cue-induced craving during craving reactivation one week later or craving and cocaine use over the 4-week follow-up period compared to the saline/craving group. There were no significant differences in craving and cocaine use between the lidocaine/relax and saline/craving groups. Lidocaine administered following craving induction did not decrease subsequent cue-induced craving or cocaine use. Blocking the reconsolidation of craving-related memories with pharmacological agents remains an important area of investigation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0376-8716
1879-0046
1879-0046
DOI:10.1016/j.drugalcdep.2020.108062